Cellectis S.A. shares rise 3.31% premarket after a late-week sell-off in global markets.

Cellectis S.A. rose 3.31% in premarket trading. The recent sell-off in global markets, with the European Stoxx 600 and the U.S. S&P 500 experiencing their steepest weekly drops in 17 and 10 weeks respectively, may have influenced the stock's movement. The sell-off was broad-based, with cyclicals being hit hardest and even defensive sectors like banking offering little protection.